- Home
- SB vs PSNL Comparison
SB vs PSNL Comparison
Compare SB & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SB
- PSNL
- Stock Information
- Founded
- SB 2007
- PSNL 2011
- Country
- SB Monaco
- PSNL United States
- Employees
- SB N/A
- PSNL N/A
- Industry
- SB Marine Transportation
- PSNL Medical Specialities
- Sector
- SB Consumer Discretionary
- PSNL Health Care
- Exchange
- SB Nasdaq
- PSNL Nasdaq
- Market Cap
- SB 395.3M
- PSNL 460.7M
- IPO Year
- SB 2008
- PSNL 2019
- Fundamental
- Price
- SB $3.41
- PSNL $5.16
- Analyst Decision
- SB Strong Buy
- PSNL Strong Buy
- Analyst Count
- SB 1
- PSNL 5
- Target Price
- SB $6.00
- PSNL $8.00
- AVG Volume (30 Days)
- SB 414.1K
- PSNL 753.6K
- Earning Date
- SB 05-20-2025
- PSNL 05-06-2025
- Dividend Yield
- SB 5.71%
- PSNL N/A
- EPS Growth
- SB 36.11
- PSNL N/A
- EPS
- SB 0.83
- PSNL N/A
- Revenue
- SB $307,633,000.00
- PSNL $85,694,000.00
- Revenue This Year
- SB N/A
- PSNL N/A
- Revenue Next Year
- SB $14.32
- PSNL $27.82
- P/E Ratio
- SB $4.08
- PSNL N/A
- Revenue Growth
- SB 8.17
- PSNL 15.57
- 52 Week Low
- SB $3.02
- PSNL $1.14
- 52 Week High
- SB $6.33
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- SB 48.48
- PSNL 73.41
- Support Level
- SB $3.32
- PSNL $3.98
- Resistance Level
- SB $3.53
- PSNL $4.49
- Average True Range (ATR)
- SB 0.09
- PSNL 0.34
- MACD
- SB 0.02
- PSNL 0.17
- Stochastic Oscillator
- SB 63.24
- PSNL 82.14
About SB Safe Bulkers Inc ($0.001 par value)
Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.